Ardent Health (ARDT) 2026 KeyBanc Capital Markets Healthcare Forum summary

Performance highlights and challenges in 2025

• Achieved strong growth in admissions, surgeries, and ER visits, with leading market share in most markets.

• Margin expansion was modest, supported by outpatient growth and acquisitions of urgent care centers.

• Faced persistent payer headwinds, especially denials and underpayments, and adverse malpractice claims in New Mexico.

• IMPACT programs drove operational improvements, focusing on margin, agility, and care transformation.

• Entering 2026, focus remains on labor performance and selective outpatient growth.

Financial outlook and headwinds for 2026

• 2025 EBITDA ended at $545 million; 2026 guidance midpoint is $510 million, reflecting payer and professional fee headwinds.

• Exchange subsidy loss quantified as a $35 million headwind, with a 20% assumed loss in HIX enrollment.

• IMPACT initiatives expected to deliver $55 million in savings, mainly from labor and supply chain.

• Core growth rate assumption is 4%, contributing a $20 million tailwind.

• EBITDA growth expected to resume in 2027 as headwinds abate.

Operational initiatives and efficiency programs

• IMPACT program targets multi-year margin improvement, focusing on labor, supply chain, and revenue cycle.

• Achieved pre-pandemic levels in contract labor costs and improved staff retention.

• AI and technology partnerships (Ensemble Health, Ambience) enhance coding, documentation, and outpatient clinic efficiency.

• Supply chain and revenue enhancement are next focus areas for cost and margin improvement.

• Program is designed for ongoing, multi-year impact, leveraging AI for future gains.